Literature DB >> 33537842

Is there an association between hypothyroidism and COVID 19? : A preliminary report.

Satvinder Singh Bakshi1, Vinoth Kumar Kalidoss2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33537842      PMCID: PMC7857644          DOI: 10.1007/s00508-021-01813-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


× No keyword cloud information.
Dear editor, The coronavirus epidemic has been declared as a public health emergency and has affected millions of people worldwide. There is evidence to suggest that people with comorbidities like diabetes, heart disease, asthma, hypertension, and cancer are more susceptible, have increased morbidity and mortality associated with the infection [1]. The evidence regarding hypothyroidism or thyroid disorders is still conflicting with some studies pointing out a correlation [2] and others refuting it [3]. We would like to share our experience in this regard. Since the beginning of the pandemic, our center has tested more than 1000 suspected cases of coronavirus disease 2019 (COVID 19) infection. The test is carried out using throat/nasal swabs and tested using RT-PCR for the viral genes. A total of 456 positive cases were detected. Among the suspect patients, 24 patients had hypothyroidism and were on replacement therapy. Of these patients 21 were reported to have COVID 19 infection through RT-PCR, this included 18 females and 3 males. Out of these 21 patients, 14 patients had other comorbidities like diabetes [2], hypertension [5] and other comorbidities [1], the other 7 had hypothyroidism alone. The average age of hypothyroid patients who were COVID 19 positive was 44.9 years (Table 1).
Table 1

Comparison of the presence of hypothyroidism and other comorbidities in COVID 19 suspect and positive cases

S. NoParameterCOVID 19 Suspect (n = 24)COVID 19 Positive (n = 21)COVID 19 Negative (n = 3)
1Age (years, mean and SD)43 (11.68)44.90 (11.41)33.33 (9.60)
2Male330
3Female21183
4Hypothyroidism alone871
5Hypothyroid + diabetes220
6Hypothyroid + hypertension550
7Hypothyroid + diabetes + hypertension862
8Hypothyroid + other comorbidities110
Comparison of the presence of hypothyroidism and other comorbidities in COVID 19 suspect and positive cases There are a few studies that have explored the development of hypothyroidism during or after the COVID infection. A study by Chen et al. [4] found that out of 50 patients with a COVID infection, 56% had lower than normal TSH (Thyroid Stimulating Hormone) levels, which was statistically significant. They also found that the degree of decrease of TSH and TT3 (Total Triiodothyronine) correlated positively with the severity of the disease. The possible mechanism can be due to the release of systemic proinflammatory cytokines or direct viral effects on the pituitary or thyroid gland. Another study done by Dosi et al. [5] found 2.7% hypothyroidism in 365 COVID patients, this increased to 3.6% in severely ill patients and patients needing mechanical ventilation 4.085%. They also found that hypothyroidism was the third common comorbidity among COVID 19 patients. Although our sample size is small and the cause for hypothyroidism has not been assessed, we would still like to point out the increased association of COVID infection and hypothyroidism in our patients. This relationship and the effect of hypothyroidism on the severity of infection and prognosis can be explored in further studies.
  5 in total

1.  Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study.

Authors:  Min Chen; Weibin Zhou; Weiwei Xu
Journal:  Thyroid       Date:  2020-07-10       Impact factor: 6.568

Review 2.  Comorbidity and its Impact on Patients with COVID-19.

Authors:  Adekunle Sanyaolu; Chuku Okorie; Aleksandra Marinkovic; Risha Patidar; Kokab Younis; Priyank Desai; Zaheeda Hosein; Inderbir Padda; Jasmine Mangat; Mohsin Altaf
Journal:  SN Compr Clin Med       Date:  2020-06-25

Review 3.  Thyroid disease in the time of COVID-19.

Authors:  Dorota Dworakowska; Ashley B Grossman
Journal:  Endocrine       Date:  2020-06-07       Impact factor: 3.633

4.  Clinical Characteristics, Comorbidities,and Outcome among 365 Patients of Coronavirus Disease 2019 at a Tertiary Care Centre in Central India.

Authors:  Ravi Dosi; Gaurav Jain; Abhishek Mehta
Journal:  J Assoc Physicians India       Date:  2020-09

5.  Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection.

Authors:  Timotius Ivan Hariyanto; Andree Kurniawan
Journal:  Diabetes Metab Syndr       Date:  2020-07-29
  5 in total
  2 in total

1.  Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry.

Authors:  Marija Bogojevic; Vikas Bansal; Vishwanath Pattan; Romil Singh; Aysun Tekin; Mayank Sharma; Abigail T La Nou; Allison M LeMahieu; Andrew C Hanson; Phillip J Schulte; Neha Deo; Shahraz Qamar; Simon Zec; Diana J Valencia Morales; Nicholas Perkins; Margit Kaufman; Joshua L Denson; Roman Melamed; Valerie M Banner-Goodspeed; Amy B Christie; Yasir Tarabichi; Smith Heavner; Vishakha K Kumar; Allan J Walkey; Ognjen Gajic; Sumit Bhagra; Rahul Kashyap; Amos Lal; Juan Pablo Domecq
Journal:  Clin Endocrinol (Oxf)       Date:  2022-02-18       Impact factor: 3.523

2.  Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry.

Authors:  Daniella Nunes Pereira; Leticia Ferreira Gontijo Silveira; Milena Maria Moreira Guimarães; Carísi Anne Polanczyk; Aline Gabrielle Sousa Nunes; André Soares de Moura Costa; Barbara Lopes Farace; Christiane Corrêa Rodrigues Cimini; Cíntia Alcantara de Carvalho; Daniela Ponce; Eliane Würdig Roesch; Euler Roberto Fernandes Manenti; Fernanda Barbosa Lucas; Fernanda d'Athayde Rodrigues; Fernando Anschau; Fernando Graça Aranha; Frederico Bartolazzi; Giovanna Grunewald Vietta; Guilherme Fagundes Nascimento; Helena Duani; Heloisa Reniers Vianna; Henrique Cerqueira Guimarães; Jamille Hemétrio Salles Martins Costa; Joanna d'Arc Lyra Batista; Joice Coutinho de Alvarenga; José Miguel Chatkin; Júlia Drumond Parreiras de Morais; Juliana Machado-Rugolo; Karen Brasil Ruschel; Lílian Santos Pinheiro; Luanna Silva Monteiro Menezes; Luciana Siuves Ferreira Couto; Luciane Kopittke; Luís César de Castro; Luiz Antônio Nasi; Máderson Alvares de Souza Cabral; Maiara Anschau Floriani; Maíra Dias Souza; Marcelo Carneiro; Maria Aparecida Camargos Bicalho; Mariana Frizzo de Godoy; Matheus Carvalho Alves Nogueira; Milton Henriques Guimarães Júnior; Natália da Cunha Severino Sampaio; Neimy Ramos de Oliveira; Pedro Ledic Assaf; Renan Goulart Finger; Roberta Xavier Campos; Rochele Mosmann Menezes; Saionara Cristina Francisco; Samuel Penchel Alvarenga; Silvana Mangeon Mereilles Guimarães; Silvia Ferreira Araújo; Talita Fischer Oliveira; Thulio Henrique Oliveira Diniz; Yuri Carlotto Ramires; Evelin Paola de Almeida Cenci; Thainara Conceição de Oliveira; Alexandre Vargas Schwarzbold; Patricia Klarmann Ziegelmann; Roberta Pozza; Caroline Scherer Carvalho; Magda Carvalho Pires; Milena Soriano Marcolino
Journal:  Int J Infect Dis       Date:  2022-01-19       Impact factor: 12.074

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.